医学分子生物学杂志 ›› 2025, Vol. 22 ›› Issue (3): 300-304.doi: 10.3870/j.issn.1672-8009.2025.03.015

• 综述 • 上一篇    

匹莫齐特在急性髓系白血病中的作用机制 #br#

  

  1. 1宁波大学附属人民医院血液科 浙江省宁波市, 315040  2宁波大学医学部 浙江省宁波市, 315211  3宁波大学血液学研究所 浙江省宁波市, 315040
  • 出版日期:2025-05-31 发布日期:2025-06-12
  • 基金资助:
    浙江省医药卫生科技计划项目 (No. 2023KY1142)

Mechanism of Pimozide in Acute Myeloid Leukemia #br# #br#

  1. 1Department of Hematology, Ningbo University Affiliated Peoples Hospital, Ningbo, Zhejiang, 315040, China 2Medical School, Ningbo University, Ningbo, Zhejiang, 315211, China  3Hematology Research Institute, Ningbo University, Ningbo, Zhejiang, 315040, China
  • Online:2025-05-31 Published:2025-06-12

摘要: 急性髓系白血病 ( acute myeloid leukemia, AML) 是一种具有高度侵袭性的血液系统恶性肿瘤目前化疗和造血干细胞移植仍是 AML 的主要治疗手段但仍有约 30 % 患者复发预后不佳。 匹莫齐特是一种抗精神病药物主要用于治疗精神分裂症、 双相情感障碍等疾病目前已有多项研究证实其具有抗肿瘤作用。 文章旨在通过分析国内外文献对匹莫齐特在 AML 中的作用机制进行综述为 AML 的治疗策略提供思路

关键词:

急性髓系白血病, 匹莫齐特

Abstract: Acute myeloid leukemia ( AML ) is a highly aggressive hematologicalmalignancy. Currently, chemotherapy and hematopoietic stem cell transplantation remain the primary treatment options for AML, yet approximately 30 % of patients experience relapse and have a poor prognosis. Pimozide, an antipsychotic drug, is primarily used in the treatment of schizophrenia, bipolar disorder, and other conditions. Several studies have now confirmed its antitumor effects. This article aims to review the mechanisms of pimozide in AML by literature analyzing, which provides insights into treatment strategies for AML.

Key words: acute myeloid leukemia, pimozide

中图分类号: